(Q43691619)

English

The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats

scientific article published in August 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

author name string

Jewett DC

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Grace MK

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jones RM

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Billington CJ

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Portoghese PS

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Levine AS

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

909

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

75-80

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Nor-binaltorphimine decreases deprivation and opioid-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

The effect of selective opioid antagonists on butorphanol-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Neuropeptide Y: a potent inducer of consummatory behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Butorphanol increases food-reinforced operant responding in satiated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Effects of beta-funaltrexamine on ingestive behaviors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902624-5

7 January 2021

Identifiers

10.1016/S0006-8993(01)02624-5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43691619&oldid=2102613755"